Session

IBD (Posters)

PATIENTS WITH NEWLY DIAGNOSED FISTULIZING PERIANAL CROHN'S DISEASE HAVE DISTINCT MICROBIAL SIGNATURE
PATIENTS WITH NEWLY DIAGNOSED FISTULIZING PERIANAL CROHN'S DISEASE HAVE DISTINCT MICROBIAL SIGNATURE

IBD (Posters)  et al.

SAFETY, TOLERABILITY AND PHARMACOKINETICS OF NX-13 IN A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 1 STUDY IN NORMAL HEALTHY VOLUNTEERS
SAFETY, TOLERABILITY AND PHARMACOKINETICS OF NX-13 IN A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 1 STUDY IN NORMAL HEALTHY VOLUNTEERS

IBD (Posters)  et al.

PSYCHOLOGICAL MORBIDITY PREDICTS MALADAPTIVE DECISION-MAKING IN PEOPLE WITH INFLAMMATORY BOWEL DISEASE
PSYCHOLOGICAL MORBIDITY PREDICTS MALADAPTIVE DECISION-MAKING IN PEOPLE WITH INFLAMMATORY BOWEL DISEASE

IBD (Posters)  et al.

SINGLE CELL RNA SEQUENCING IDENTIFIES DISTINCT INTESTINAL INFLAMMATION PATTERNS BETWEEN PRIMARY SCLEROSING CHOLANGITIS-ASSOCIATED COLITIS AND ULCERATIVE COLITIS
SINGLE CELL RNA SEQUENCING IDENTIFIES DISTINCT INTESTINAL INFLAMMATION PATTERNS BETWEEN PRIMARY SCLEROSING CHOLANGITIS-ASSOCIATED COLITIS AND ULCERATIVE COLITIS

IBD (Posters)  et al.

COLORECTAL CANCER SURVEILLANCE IN COMPLEX IBD PATIENTS WITH STRICTURES
COLORECTAL CANCER SURVEILLANCE IN COMPLEX IBD PATIENTS WITH STRICTURES

IBD (Posters)

DIGESTIVE FISTULAS IN CROHN'S DISEASE (CD) OTHER THAN ANO-PERINEAL MANIFESTATIONS (APM): WHAT PROGNOSIS?
DIGESTIVE FISTULAS IN CROHN'S DISEASE (CD) OTHER THAN ANO-PERINEAL MANIFESTATIONS (APM): WHAT PROGNOSIS?

IBD (Posters)  et al.

HUMAN NEUTROPHIL ELASTASE DERIVED FRAGMENT OF CALPROTECTIN (S100A9) IS A SERUM BIOMARKER (CPA9-HNE) FOR MONITORING OF ANTI-TNFA TREATMENT RESPONSE IN CROHN’S DISEASE
HUMAN NEUTROPHIL ELASTASE DERIVED FRAGMENT OF CALPROTECTIN (S100A9) IS A SERUM BIOMARKER (CPA9-HNE) FOR MONITORING OF ANTI-TNFA TREATMENT RESPONSE IN CROHN’S DISEASE

IBD (Posters)  et al.

WATCH OUT FOR SIGNS OF ANXIETY AND DEPRESSION IN IBD PATIENTS DURING AN ACUTE FLARE-UP
WATCH OUT FOR SIGNS OF ANXIETY AND DEPRESSION IN IBD PATIENTS DURING AN ACUTE FLARE-UP

IBD (Posters)  et al.

CELIAC DISEASE AMONG A LARGE INFLAMMATORY BOWEL DISEASE POPOULATION: EPIDEMIOLOGY AND OUTCOME
CELIAC DISEASE AMONG A LARGE INFLAMMATORY BOWEL DISEASE POPOULATION: EPIDEMIOLOGY AND OUTCOME

IBD (Posters)  et al.

AUDIT: IS CO-TRIMOXAZOLE PROPHYLAXIS NECESSARY FOR INFLAMMATORY BOWEL DISEASE PATIENTS RECEIVING TRIPLE IMMUNOSUPPRESSION?
AUDIT: IS CO-TRIMOXAZOLE PROPHYLAXIS NECESSARY FOR INFLAMMATORY BOWEL DISEASE PATIENTS RECEIVING TRIPLE IMMUNOSUPPRESSION?

IBD (Posters)  et al.

DRUG MONITORING OF BIOTHERAPIES IN CHRONIC INFLAMMATORY BOWEL DISEASES
DRUG MONITORING OF BIOTHERAPIES IN CHRONIC INFLAMMATORY BOWEL DISEASES

IBD (Posters)  et al.

MULTIPLE SCLEROSIS PREVALENCE IN HIGHER IN CROHN’S DISEASE PATIENTS THAN IN GENERAL POPULATION, BUT DOES NOT INFLUENCE INFLAMMATORY BOWEL DISEASE OUTCOME
MULTIPLE SCLEROSIS PREVALENCE IN HIGHER IN CROHN’S DISEASE PATIENTS THAN IN GENERAL POPULATION, BUT DOES NOT INFLUENCE INFLAMMATORY BOWEL DISEASE OUTCOME

IBD (Posters)  et al.

NEITHER INFLAMMATORY BOWEL DISEASE NOR IMMUNOSUPPRESSANTS ARE ASSOCIATED WITH AN INCREASED RISK FOR SEVERE COVID-19. AN OBSERVATIONAL DUTCH COHORT-STUDY
NEITHER INFLAMMATORY BOWEL DISEASE NOR IMMUNOSUPPRESSANTS ARE ASSOCIATED WITH AN INCREASED RISK FOR SEVERE COVID-19. AN OBSERVATIONAL DUTCH COHORT-STUDY

IBD (Posters)  et al.

LOCALLY INJECTED ALLOGENEIC BONE MARROW-DERIVED MESENCHYMAL STROMAL CELLS FOR THE TREATMENT OF REFRACTORY PROCTITIS: PRELIMINARY RESULTS OF A PHASE IIA TRIAL
LOCALLY INJECTED ALLOGENEIC BONE MARROW-DERIVED MESENCHYMAL STROMAL CELLS FOR THE TREATMENT OF REFRACTORY PROCTITIS: PRELIMINARY RESULTS OF A PHASE IIA TRIAL

IBD (Posters)  et al.

IMPACT OF APPENDECTOMY ON THE NATURAL HISTORY OF CROHN'S DISEASE
IMPACT OF APPENDECTOMY ON THE NATURAL HISTORY OF CROHN'S DISEASE

IBD (Posters)  et al.

EXPRESSION PROFILING OF WNT PATHWAY GENES IN COLON BIOPSIES OF PATIENTS WITH ULCERATIVE COLITIS AND CROHN’S DISEASE
EXPRESSION PROFILING OF WNT PATHWAY GENES IN COLON BIOPSIES OF PATIENTS WITH ULCERATIVE COLITIS AND CROHN’S DISEASE

IBD (Posters)  et al.

BROAD HOST RANGE BACTERIOPHAGE THERAPY FOR REDUCTION OF KLEBSIELLA PNEUMONIAE AS A POTENTIAL TREATMENT IN IBD
BROAD HOST RANGE BACTERIOPHAGE THERAPY FOR REDUCTION OF KLEBSIELLA PNEUMONIAE AS A POTENTIAL TREATMENT IN IBD

IBD (Posters)  et al.

PSYCHOSOCIAL IMPACT OF THE COVID-19 PANDEMIC ON PATIENTS WITH INFLAMMATORY BOWEL DISEASE IN SPAIN
PSYCHOSOCIAL IMPACT OF THE COVID-19 PANDEMIC ON PATIENTS WITH INFLAMMATORY BOWEL DISEASE IN SPAIN

IBD (Posters)  et al.

SURGICAL TREATMENT IN PATIENTS WITH ULCERATIVE COLITIS: CLINICAL ASPECTS AND ASSOCIATED FACTORS
SURGICAL TREATMENT IN PATIENTS WITH ULCERATIVE COLITIS: CLINICAL ASPECTS AND ASSOCIATED FACTORS

IBD (Posters)  et al.

HISTOLOGICAL INFLAMMATION PREDICTS LOSS OF REMISSION AMONG CROHN’S PATIENTS WITH ENDOSCOPIC REMISSION: A US COHORT ANALYSIS
HISTOLOGICAL INFLAMMATION PREDICTS LOSS OF REMISSION AMONG CROHN’S PATIENTS WITH ENDOSCOPIC REMISSION: A US COHORT ANALYSIS

IBD (Posters)  et al.

Item 481 - 500 / 568
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24
25
26 27 28 29